Insider Trading & Ownership - Kelly James Patrick

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Kelly James Patrick
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-03-02
Sale
2020-03-04
5:01 pm
Vanda Pharmaceuticals Inc.VNDAKelly James Patrick
EVP & Chief Financial Officer
18,857$10.36$195,446186,869
(Direct)
View
2020-01-02
Sale
2020-01-06
5:25 pm
Vanda Pharmaceuticals Inc.VNDAKelly James Patrick
EVP & Chief Financial Officer
4,020$15.94$64,086205,726
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-08-16
Tax Withholding
2024-08-20
5:06 pm
N/A
N/A
NOVAVAX INCKelly James Patrick
EVP, CFO and Treasurer
1,223$12.9614,429
(Direct)
View
2024-08-16
Exercise
2024-08-20
5:06 pm
N/A
2031-08-16
NOVAVAX INCKelly James Patrick
EVP, CFO and Treasurer
2,367$014,429
(Direct)
View
2024-08-16
Exercise
2024-08-20
5:06 pm
N/A
N/A
NOVAVAX INCKelly James Patrick
EVP, CFO and Treasurer
2,367$12.9614,429
(Direct)
View
2024-03-01
Option Award
2024-03-26
7:01 pm
N/A
N/A
NOVAVAX INCKelly James Patrick
EVP, CFO & Treasurer
176,000$0176,000
(Direct)
View
2024-03-10
Tax Withholding
2024-03-12
8:46 pm
N/A
N/A
NOVAVAX INCKelly James Patrick
EVP, CFO and Treasurer
2,226$5.4517,893
(Direct)
View
2024-03-10
Exercise
2024-03-12
8:46 pm
N/A
N/A
NOVAVAX INCKelly James Patrick
EVP, CFO and Treasurer
4,608$017,893
(Direct)
View
2024-03-07
Tax Withholding
2024-03-11
9:39 pm
N/A
N/A
NOVAVAX INCKelly James Patrick
EVP, CFO and Treasurer
5,905$5.6170,349
(Direct)
View
2023-09-12
Option Award
2024-03-11
9:39 pm
N/A
N/A
NOVAVAX INCKelly James Patrick
EVP, CFO and Treasurer
35,000$070,349
(Direct)
View
2024-03-07
Exercise
2024-03-11
9:39 pm
N/A
N/A
NOVAVAX INCKelly James Patrick
EVP, CFO and Treasurer
12,224$070,349
(Direct)
View
2023-08-16
Tax Withholding
2023-08-18
4:37 pm
N/A
N/A
NOVAVAX INCKelly James Patrick
EVP, CFO and Treasurer
1,143$7.136,951
(Direct)
View
2023-08-16
Exercise
2023-08-18
4:37 pm
N/A
N/A
NOVAVAX INCKelly James Patrick
EVP, CFO and Treasurer
2,366$06,951
(Direct)
View
2023-03-10
Tax Withholding
2023-03-14
5:19 pm
N/A
N/A
NOVAVAX INCKelly James Patrick
EVP, CFO and Treasurer
2,471$6.5212,577
(Direct)
View
2023-03-10
Exercise
2023-03-14
5:19 pm
N/A
N/A
NOVAVAX INCKelly James Patrick
EVP, CFO and Treasurer
4,609$012,577
(Direct)
View
2023-03-10
Exercise
2023-03-14
5:19 pm
N/A
N/A
NOVAVAX INCKelly James Patrick
EVP, CFO and Treasurer
4,609$6.5212,577
(Direct)
View
2023-03-07
Option Award
2023-03-09
5:01 pm
2024-03-07
2033-03-07
NOVAVAX INCKelly James Patrick
EVP, CFO and Treasurer
79,020$079,020
(Direct)
View
2022-08-16
Tax Withholding
2022-08-18
5:02 pm
N/A
N/A
NOVAVAX INCKelly James Patrick
EVP, CFO and Treasurer
1,144$42.885,956
(Direct)
View
2022-08-16
Exercise
2022-08-18
5:02 pm
N/A
N/A
NOVAVAX INCKelly James Patrick
EVP, CFO and Treasurer
2,367$05,956
(Direct)
View
2022-03-10
Option Award
2022-03-14
7:48 pm
N/A
2032-03-10
NOVAVAX INCKelly James Patrick
EVP, CFO and Treasurer
34,562$034,562
(Direct)
View
2021-08-16
Option Award
2021-08-18
5:16 pm
N/A
N/A
NOVAVAX INCKelly James Patrick
EVP, CFO and Treasurer
21,300$021,300
(Direct)
View
2021-02-19
Option Award
2021-02-23
6:55 pm
N/A
2031-02-19
SUPERNUS PHARMACEUTICALS INC.SUPNKelly James Patrick
Executive Vice-President & CFO
15,000$015,000
(Direct)
View
2020-10-12
Option Award
2020-10-13
12:03 pm
N/A
2030-10-12
SUPERNUS PHARMACEUTICALS INC.SUPNKelly James Patrick
Executive Vice-President & CFO
135,000$0135,000
(Direct)
View